Overview

A Study of Pemetrexed in Small Cell Lung Cancer, Which Has Returned

Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
The purposes of this study are to determine 1) the safety of pemetrexed and any side effects that might be associated with it 2) whether pemetrexed can help patients with small cell lung cancer live longer 3) whether pemetrexed can make tumors smaller or disappear and for how long and 4) to see if patients feel better while taking pemetrexed
Phase:
Phase 2
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Pemetrexed